Management of thyroid diseases during pregnancy;Postȩpowanie w chorobach tarczycy u kobiet w cia̧ży

Endokrynologia Polska

Volumn 62, Issue 4, 2011, Pages 362-381

  Hubalewska Dydejczyk, Alicja ^a   Lewiński, Andrzej ^h   Milewicz, Andrzej ⁱ   Radowicki, Stanisław ^c   Porȩba, Ryszard ^j   Karbownik Lewińska, Małgorzata ^h   Kostecka Matyja, Marta ^a   Trofimiuk Müldner, Małgorzata ^a   Pach, Dorota ^a   Zygmunt, Arkadiusz ^h   Bandurska Stankiewicz, Elzbieta ^b   Bar Andziak, Ewa ^c   Bednarczuk, Tomasz ^c   Buziak Bereza, Monika ^a   Drews, Krzysztof ^d   Gietka Czernel, Małgorzata ^e   Górska, Maria ^f   Jastrzȩbska, Helena ^e   Junik, Roman ^g   Nauman, Janusz ^c   Niedziela, Marek ^d   Reroń, Alfred ^a   Sowiński, Jerzy ^d   Sworczak, Krzysztof ^k   Syrenicz, Anhelli ^l   Zgliczyński, Wojciech ^e   more..

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^e MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^f MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^g NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^h MEDICAL UNIVERSITY OF LODZ   (Poland)

ⁱ WROCLAW MEDICAL UNIVERSITY   (Poland)

^j MEDICAL UNIVERSITY OF SILESIA   (Poland)

^k MEDICAL UNIVERSITY OF GDANSK   (Poland)

^l POMERANIAN MEDICAL UNIVERSITY   (Poland)

more..

Author keywords

Endocrine care; Fetal development; Obsterical complications; Thyroid disorders

Indexed keywords

IODINE; THYROID HORMONE;

ETHNIC DIFFERENCE; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONAL THERAPY; HUMAN; MATERNAL CARE; NUTRITIONAL STATUS; PREGNANT WOMAN; REVIEW; RISK; SOCIAL STATUS; SUBFERTILITY; THYROID DISEASE; ARTICLE; DRUG EFFECT; FETOMATERNAL TRANSFUSION; FETUS DEVELOPMENT; METABOLISM; POLAND; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION;

FEMALE; FETAL DEVELOPMENT; HUMANS; MATERNAL-FETAL EXCHANGE; POLAND; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; THYROID DISEASES; THYROID HORMONES;

EID: 80052579630     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Abalovich M., Amino N., Barbour L.A. et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007; 92 (8 Suppl): S1-S47. (Pubitemid 47236338)
2. Banhadi N., Wiersinga W.M., Reitsma J.B., Vrijkotte T.G.M., Van der Wal M.F., Bonsel G.J. Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy. Clin Endocrinol 2007; 66: 765-770. (Pubitemid 47024260)
3. Cotzias C., Wong S.J., Taylor E., Seed P., Girling J. A study to establish gestation-specific reference intervals for thyroid function tests in normal singleton pregnancy. Eur J Obstet Gynecol Reprod Biol 2008; 137: 61-66.
4. Karbownik-Lewińska M. Thyroid dysfunction during pregnancy. Invited Lecture. 11th European Congress of Endocrinology 25-29.04.2009 r., Istanbul, Turcja, Endocr. Abstr. 2009; 20, S26.2.
5. Karbownik-Lewińska M., Zygmunt A. Choroby endokrynologiczne u kobiet w cia̧ży i w okresie fizjologicznej laktacji. In: Lewiński A, Zygmunt A (eds). Diagnostyka czynnościowa zaburzeń hormonalnych z elementami diagnostyki różnicowej. Czelej, Lublin 2011: 241-250.
6. Lambert-Messarlian G., Mcclain M., Haddow J.E. et al. and the FaSTER Consortium. First and second trimester thyroid hormone reference data in pregnant women: a FaSTER (First and Second Trimester Evaluation of Risk for aneuploidy) Research Consortium study. Am J Obstet Gynecol 2008; 1999: 62e.1-62e6.
7. La'Ulu S.L., Roberts W.L. Second-trimester reference intervals for thyroid tests: The role of ethnicity. Clinical Chemistry 2007; 53: 1658-1664. (Pubitemid 47340063)
8. Springer D., Zima T., Limanova Z. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol 2009; 160: 791-797.
9. Stricker Rt, Echenard M, Eberhard R et al. Evaluation of maternal thyroid function during pregnancy: The importance of using gestational age-specific reference intervals. Eur J Endocrinol 2007; 157: 509-514.
10. Gietka-Czernel M., Dȩbska M., Kretowicz P. et al. Tarczyca płodu w ultrasonografii 2 i 3- Wymiarowej. Nomogramy w oparciu o wiek cia̧żowy i wymiar dwuciemieniowy. Endokrynol Pol- Polish J Endocrinol 2008; 59 (suppl A): 156.
11. WHO, Unicef, ICCIDD. Assessment of Iodine deficiency disorders and monitoring their elimination. A Guide for Programme Managers. Third edition, WHO 2007.
12. Lauberg P., Andersen S., Bjarnadottir R.I. et al. Evaluating iodine deficiency in pregnant women and young infants - Complex physiology with a risk of misinterpretation. Public Health Nutrition 2007; 10: 1547-1552. (Pubitemid 350224311)
13. Orito Y., Oku S., Kubota S. et al. Thyroid function in early pregnancy in Japanese healthy women: Relation to urinary iodine excretion, emesis, and fetal and child development. J Clin Endocrinol Metab 2009; 94: 1683-1688.
14. Lewiński A., Zygmunt A., Karbownik-Lewińska M., Słowińska-Klencka D., Popowicz B., Klencki M. Detrimental Effects of Increasing Iodine Supply: Iodine-Induced Hyperthyroidism Following Iodine Prophylaxis. In: Preedy VR, Burrow GN, Ross Watson R (eds). Comprehensive Handbook of Iodine. Nutricional, Biochemical, Pathological and Therapeutic Aspects. Academic Press, Elsevier, 2009: 871-876.
15. European Commission HaCPD-GSCoF. Opinion of the Scientific Committee on Food on the tolerable upper intake level of iodine. Brussels, European Commision, 2002 (SCF/CS/NUT/UPPLEV/26 Final).
16. Institute of Medicine. Dietary Reference Intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. National Academy Press, Washington 2002.
17. Zdebski Z., Kalita J., Kiam I. et al. Analysis of the course of pregnancy, parturition and of the condition of the children born by women with iodine deficiency; effects of kalium iodide supplementation. Polish J Endocrinology 1998; 49 (suppl 1 3): 163-170.
18. Gołkowski F., Bałdys-Waligórska A., Huszno B., Szybinski Z. Goitre prevalence and urinary excretion in pregnant women. Polish J Endocrinol 1998; 49 (suppl 1): 183-189.
19. Sobieszczańska-Jabłońska A., Lewiński A., Karbownik M., Krekora M., Tomaszewski W., Koptas W. Effects of iodine prophylaxis and of levothyroxine treatment on clinical and biochemical indicators of excessive thyroid stimulation in pregnant women and newborns. Polish J Endocrinol 1998; 49 (suppl 1): 171-182.
20. Kamiński M., Drewniak W., Szymański W., Junik R., Kamińska A. Urinary iodine excretion and thyroid function in pregnant women of Bydgoszcz District prior to and after the introduction of iodized salt. Ginekol Pol 2003; 74: 1126-1129.
21. Bodzek P., Olejnik A., Zamłyński J. Iodine concentration with urine and thyrotrophic hormone concentration in normal and complicated pregnancies in the industrial region of iodine deficiency. Wiad Lek 2006; 59: 612-617.
22. Gietka-Czernel M., Dȩbska M., Kretowicz P. et al. Iodine status of pregnant women from central Poland 10 years after introduction of iodine prophylaxis program. Endokrynol Pol - Polish J Endocrinol 2010; 61: 646-651.
23. Dosiou C., Sanders G.D., Araki S.S., Crapo L.M. Screening pregnant women for autoimmune thyroid disease: A cost-effectiveness analysis. Eur J Endocrinol 2008; 158: 841-851. (Pubitemid 351837373)
24. Moleti M., Lo Presti V.P., Mattina F. et al. Gestational thyroid function abnormalities in conditions of mild iodine deficiency: Early screening versus continuous monitoring of maternal thyroid status. Eur J Endocrinol 2009; 160: 611-617.
25. Negro R., Schwartz A., Gismondi R., Tinelli A., Mangeri T., Stangaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010; 95: E44-E48.
26. Negro R., Schwarz A., Gismondi R., Tinelli A., Mangieri T., Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010; 95: 1699-1707.
27. Thung S.F., Funai E.F., Grobman WA. The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism. Am J Obstetr Gynecol 2009; 200: e1-267-e7.
28. Vaidya B., Anthony S., Bilous M. et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high risk case finding? J Clin Endocrinol Metab 2007; 92: 203-207. (Pubitemid 46067531)
29. Mestman J.H. Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 2004; 18: 267-288.
30. Rotondi M., Cappelli C., Pirali B. et al. The effect of pregnancy on subsequent relapse from Graves' disease after successful course of antithyroid drug therapy. J Clin Endocrinol Metab 2008; 93: 3985-3988.
31. Laurberg P., Bournaud C., Karmisholt J., Orgiazzi J. Management of Graves' hyperthyroidism in pregnancy: Focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009; 160: 1-8.
32. Bahn R.S., Burch H.S., Cooper D.S. et al. The role of propylthiouracil in the management of Graves' disease in adults: Report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 2009; 19: 673-674.
33. Cooper D.S., Rivkees S.A. Putting propylothiouracil in perspective. J Clin Endocrinol Metab 2009; 94: 1881-1182.
34. Banhadi N., Wiersinga W.M., Reitsma J.B., Vrijkotte T.G.M., Bonsel G.J. Higher maternal TSH levels in pregnancy are associated with increased risk of miscarriage, fetal or neonatal death. Eur J Endocrinol 2009; 160: 985-991.
35. De Vivi A., Mancuso A., Giaccobbe A. et al. Thyroid function in women found to have early pregnancy loss. Thyroid 2010; 20: 633-637.
36. Hamm M.P., Cherry N.M., Martin J.W., Bamforth F., Edmonton A.B. The impact of isolated maternal hypothyroxinemia on perinatal morbidity. J Obstet Gynaecol Can 2009; 31: 1015-1021.
37. Henrichs J., Bongers-Schokking J.J., Schenk J.J. et al. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: The generation R study. J Clin Endocrinol Metab 2010; 95: 4227-4234.
38. Li Y., Shan Z., Teng W. et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol 2010; 72: 825-829.
39. Oken E., Braverman L.E., Platek D., Mitchell M.L., Lee S.L., Pearce E.N. Neonatal thyroxine, maternal function and child cognition. J Clin Endocrinol Metab 2009; 94: 497-503.
40. Sahu M.T., Das V., Mittal S., Agarwal A., Sahu M. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet 2010; 81: 215-220.
41. Jastrzȩbska H., Gietka-Czernel M., Zgliczyński S., Cech W., Lewartowska A., Dȩbski R. Pregnancy in women with thyroid cancer treated with suppressive doses of L-thyroxine. Wiad Lek 2001; 54 (suppl 1): 389-397.
42. Loh J.A., Wartofsky L., Jonklaas J., Durman K.D. The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the ethiology of the hypothyroidism. Thyroid 2009; 19: 269-275.
43. Yassa L., Marquesee E., Fawcett R., Alexander E.K. Thyroid hormone early adjustment in pregnancy (The THERAPY) trial. J Clin Endocrinol Metab 2010; 95: 3234-3241.
44. Abalovich M., Alcaraz G., Kleiman-Rubinsztein J., Pavlove M.M., Cornelio C., Gutierrez S. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid 2010; 20: 1175-1178.
45. Bańkowska E.M., Pawłowska A., Leibschang J. Thyroid function test in pregnant women with pregnancy induced hypertension. Ginekol Pol 2001; 74: 1044-1048.
46. Iravatani A.T., Saeedi M.M., Pakravesh J., Hamidi S., Abbasi M. Thyroid autoimmunity and recurrent spontaneous abortion in Iran: A case-control study. Endocr Pract 2008; 14: 458-464.
47. Mannisto T., Vaarasmaki M., Pouta A. et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: A prospective population-based cohort study. J Clin Endocrinol Metab 2009; 94: 772-779.
48. Wasserman E.E., Nelson K., Rose N.R. et al. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: An epidemiologic assessment. Am J Epidemiol 2008; 167: 701-710. (Pubitemid 351430928)
49. Sher G., Massarani G., Zouves C. et al. The use of combined heparin/aspirin and IgG therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. Am J Reprod Immunol 1998; 39: 223-225. (Pubitemid 28116139)
50. Negro R., Formoso G., Mangieri T., Pezzarossa A., Dazzi D., Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: Effects on obstetrical complications. J Clin Endocrinol Metab 2006; 91: 2587-2591. (Pubitemid 44024622)
51. Negro R., Greco G., Mangieri T., Pezzarossa A., Dazzi D., Hassan H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase antibodies. J Clin Endocrinol Metab 2007; 92: 1263-1268. (Pubitemid 46556396)
52. Cooper D.S., Doherty G.M., Haugen B.R. et al. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214.
53. Polska Grupa ds. Nowotworów Endokrynnych. Jarza̧b B, Sporny S, Lange D, Włoch J, Lewiński A (eds). Diagnostyka i leczenie raka tarczycy - rekomendacje polskie. Endokrynol Pol 2010; 61: 518-568.
54. Kuy S., Roman S.A., Desai R., Sosa J.A. Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg 2009; 144: 399-406.
55. Vannucchi G., Perrino M., Rossi S., Colombo C., Vicentini L., Dazzi D. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol 2010; 162: 145-151.
56. Toulis K.A., Goulis D.G., Venetis C.A. et al. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: A meta-analysis. Eur J Endocrinol 2010; 162: 643-652.
57. Garsi J.P., Schlumberger M., Rubino C. et al. Therapeutic administration of 131I for differentiated thyroid cancer: Radiation dose to ovaries and outcome of pregnancies. J Nucl Med 2008; 49: 845-852. (Pubitemid 351717552)